{"id":11334,"date":"2020-03-25T15:04:09","date_gmt":"2020-03-25T14:04:09","guid":{"rendered":"https:\/\/pharmanutra.it\/two-news-patents-approved-in-india-and-usa\/"},"modified":"2025-04-11T15:46:35","modified_gmt":"2025-04-11T13:46:35","slug":"two-news-patents-approved-in-india-and-usa","status":"publish","type":"post","link":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/","title":{"rendered":"Two news patents approved in India and USA"},"content":{"rendered":"<h2>The Group obtains approval of the Cetilar<sup>\u00ae\u00a0<\/sup>patent in the USA and new prospects unfold for SiderAL<sup>\u00ae<\/sup> in India thanks to a new patent linked to the Sucrosomial<sup>\u00ae<\/sup> Technology being granted. Expansion continues in Europe where a new agreement is stipulated with the Bulgarian company Naturpharma.<\/h2>\n<p>&nbsp;<br \/>\nPharmaNutra announces that it has obtained <strong>two new assets<\/strong>, strategic for the Group\u2019s international expansion. <strong>Two patents have been approved in India and the United States<\/strong> respectively &#8211; markets with considerable potential given their size &#8211; to further strengthen the foreign presence of the Tuscan company founded by the Lacorte brothers.<\/p>\n<p>&nbsp;<br \/>\nFor what concerns <strong>India<\/strong>, the patent approved is for <strong>\u201cSolid Iron\u201d (number 328725)<\/strong> and will expire in 2033. The patent refers to the SiderAL<sup>\u00ae<\/sup> trademark line, created thanks to the innovative Sucrosomial<sup>\u00ae<\/sup> Technology that has enabled the PharmaNutra flagship products to overcome the limits and problems caused by administration of oral iron, a mineral with reduced absorption and low gastrointestinal tolerability. This unique, patented action mechanism has enabled PharmaNutra supplements to gain a foothold as the most effective and innovative in the sector. So much so, that for the latest market IQVIA data formalised by FederSalus,<a href=\"https:\/\/www.pharmanutra.it\/en\/news\/sideral-forte-complemento-nutrizionale-piu-venduto-in-italia\/\"> SiderAL<sup>\u00ae<\/sup> Forte 20 capsules is the nutritional supplement that sells most in Italy<\/a>.<\/p>\n<p>&nbsp;<br \/>\nThe second patent concerns Cetilar<sup>\u00ae<\/sup>, the product line studied to reduce the painful post-trauma symptoms in muscles and joints, now officially recognised on the US market. Approval of the <strong>new Cetilar<sup>\u00ae<\/sup> patent (number US10,597,608, approved on 24-3-2020) in the USA<\/strong> will last until 2036 and is a fundamental step forwards in the spread of a brand that in Italy &#8211; also thanks to a number of top level sports partnerships &#8211; has acquired a solid reputation.<\/p>\n<p>&nbsp;<br \/>\nThe Cetilar<sup>\u00ae<\/sup> brand will also be present in <strong>Bulgaria<\/strong>, thanks to a recent agreement finalised by PharmaNutra S.p.A. with <strong>Naturpharma<\/strong>, a company founded in 1997 and constantly on the lookout for innovative products for the Bulgarian market.<\/p>\n<p>&nbsp;<br \/>\n<em>\u201cIndia and the United States are two of the most important key markets globally. The fact that local authorities have officially acknowledged the value of our patents is a significant step forwards for the PharmaNutra Group\u201d<\/em>, <strong>the President, Andrea Lacorte declares<\/strong>. <em>\u201cHowever, our scientific research continues non-stop as we are encouraged to improve and take PharmaNutra science to an even higher level\u201d<\/em>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Group obtains approval of the Cetilar\u00ae\u00a0patent in the USA and new prospects unfold for SiderAL\u00ae in India thanks to a new patent linked to the Sucrosomial\u00ae Technology being granted. Expansion continues in Europe where a new agreement is stipulated with the Bulgarian company Naturpharma. &nbsp; PharmaNutra announces that it has obtained two new assets, [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":2883,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[47],"tags":[139,136],"anno_documento":[91],"class_list":["post-11334","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-events","tag-eventi-en","tag-research-and-technology","anno_documento-2020-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Two news patents approved in India and USA - pharmanutra.it<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Two news patents approved in India and USA - pharmanutra.it\" \/>\n<meta property=\"og:description\" content=\"The Group obtains approval of the Cetilar\u00ae\u00a0patent in the USA and new prospects unfold for SiderAL\u00ae in India thanks to a new patent linked to the Sucrosomial\u00ae Technology being granted. Expansion continues in Europe where a new agreement is stipulated with the Bulgarian company Naturpharma. &nbsp; PharmaNutra announces that it has obtained two new assets, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"pharmanutra.it\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-25T14:04:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-11T13:46:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2019\/02\/News-accordi-Grecia-e-Ucraina.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Silvia Rigotto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silvia Rigotto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/\"},\"author\":{\"name\":\"Silvia Rigotto\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/e167594e059fd908b48f144590a46ccd\"},\"headline\":\"Two news patents approved in India and USA\",\"datePublished\":\"2020-03-25T14:04:09+00:00\",\"dateModified\":\"2025-04-11T13:46:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/\"},\"wordCount\":393,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2019\/02\/News-accordi-Grecia-e-Ucraina.png\",\"keywords\":[\"Eventi\",\"Research and Technology\"],\"articleSection\":[\"News &amp; Events\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/\",\"url\":\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/\",\"name\":\"Two news patents approved in India and USA - pharmanutra.it\",\"isPartOf\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2019\/02\/News-accordi-Grecia-e-Ucraina.png\",\"datePublished\":\"2020-03-25T14:04:09+00:00\",\"dateModified\":\"2025-04-11T13:46:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#primaryimage\",\"url\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2019\/02\/News-accordi-Grecia-e-Ucraina.png\",\"contentUrl\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2019\/02\/News-accordi-Grecia-e-Ucraina.png\",\"width\":1200,\"height\":630,\"caption\":\"pharmanutra sigla nuovi accordi per la distribuzione internazionale di sideral e cetilar\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.pharmanutra.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Two news patents approved in India and USA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#website\",\"url\":\"https:\/\/www.pharmanutra.it\/en\/\",\"name\":\"pharmanutra.it\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.pharmanutra.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#organization\",\"name\":\"pharmanutra.it\",\"url\":\"https:\/\/www.pharmanutra.it\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/09\/PHN_LOGO2020color.png\",\"contentUrl\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/09\/PHN_LOGO2020color.png\",\"width\":1856,\"height\":210,\"caption\":\"pharmanutra.it\"},\"image\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/e167594e059fd908b48f144590a46ccd\",\"name\":\"Silvia Rigotto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/74de320c47466acb3ce41afd90e724ba09607692eb64df19e5d1a3518ea9984c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/74de320c47466acb3ce41afd90e724ba09607692eb64df19e5d1a3518ea9984c?s=96&d=mm&r=g\",\"caption\":\"Silvia Rigotto\"},\"url\":\"https:\/\/www.pharmanutra.it\/en\/author\/s-rigotto\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Two news patents approved in India and USA - pharmanutra.it","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/","og_locale":"en_US","og_type":"article","og_title":"Two news patents approved in India and USA - pharmanutra.it","og_description":"The Group obtains approval of the Cetilar\u00ae\u00a0patent in the USA and new prospects unfold for SiderAL\u00ae in India thanks to a new patent linked to the Sucrosomial\u00ae Technology being granted. Expansion continues in Europe where a new agreement is stipulated with the Bulgarian company Naturpharma. &nbsp; PharmaNutra announces that it has obtained two new assets, [&hellip;]","og_url":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/","og_site_name":"pharmanutra.it","article_published_time":"2020-03-25T14:04:09+00:00","article_modified_time":"2025-04-11T13:46:35+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2019\/02\/News-accordi-Grecia-e-Ucraina.png","type":"image\/png"}],"author":"Silvia Rigotto","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Silvia Rigotto","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#article","isPartOf":{"@id":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/"},"author":{"name":"Silvia Rigotto","@id":"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/e167594e059fd908b48f144590a46ccd"},"headline":"Two news patents approved in India and USA","datePublished":"2020-03-25T14:04:09+00:00","dateModified":"2025-04-11T13:46:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/"},"wordCount":393,"commentCount":0,"publisher":{"@id":"https:\/\/www.pharmanutra.it\/en\/#organization"},"image":{"@id":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2019\/02\/News-accordi-Grecia-e-Ucraina.png","keywords":["Eventi","Research and Technology"],"articleSection":["News &amp; Events"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/","url":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/","name":"Two news patents approved in India and USA - pharmanutra.it","isPartOf":{"@id":"https:\/\/www.pharmanutra.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#primaryimage"},"image":{"@id":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2019\/02\/News-accordi-Grecia-e-Ucraina.png","datePublished":"2020-03-25T14:04:09+00:00","dateModified":"2025-04-11T13:46:35+00:00","breadcrumb":{"@id":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#primaryimage","url":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2019\/02\/News-accordi-Grecia-e-Ucraina.png","contentUrl":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2019\/02\/News-accordi-Grecia-e-Ucraina.png","width":1200,"height":630,"caption":"pharmanutra sigla nuovi accordi per la distribuzione internazionale di sideral e cetilar"},{"@type":"BreadcrumbList","@id":"https:\/\/www.pharmanutra.it\/en\/two-news-patents-approved-in-india-and-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pharmanutra.it\/en\/"},{"@type":"ListItem","position":2,"name":"Two news patents approved in India and USA"}]},{"@type":"WebSite","@id":"https:\/\/www.pharmanutra.it\/en\/#website","url":"https:\/\/www.pharmanutra.it\/en\/","name":"pharmanutra.it","description":"","publisher":{"@id":"https:\/\/www.pharmanutra.it\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pharmanutra.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.pharmanutra.it\/en\/#organization","name":"pharmanutra.it","url":"https:\/\/www.pharmanutra.it\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pharmanutra.it\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/09\/PHN_LOGO2020color.png","contentUrl":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/09\/PHN_LOGO2020color.png","width":1856,"height":210,"caption":"pharmanutra.it"},"image":{"@id":"https:\/\/www.pharmanutra.it\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/e167594e059fd908b48f144590a46ccd","name":"Silvia Rigotto","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/74de320c47466acb3ce41afd90e724ba09607692eb64df19e5d1a3518ea9984c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/74de320c47466acb3ce41afd90e724ba09607692eb64df19e5d1a3518ea9984c?s=96&d=mm&r=g","caption":"Silvia Rigotto"},"url":"https:\/\/www.pharmanutra.it\/en\/author\/s-rigotto\/"}]}},"meta_box":[],"_links":{"self":[{"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/posts\/11334","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/comments?post=11334"}],"version-history":[{"count":1,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/posts\/11334\/revisions"}],"predecessor-version":[{"id":16648,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/posts\/11334\/revisions\/16648"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/media\/2883"}],"wp:attachment":[{"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/media?parent=11334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/categories?post=11334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/tags?post=11334"},{"taxonomy":"anno_documento","embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/anno_documento?post=11334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}